Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-FR Version v3-FR
Language French French
Date Updated 2021-12-10 2021-12-10
Drug Identification Number 02236876 02236876
Brand name ALPHAGAN ALPHAGAN
Common or Proper name ALPHAGAN 0.2% Ophthalmic Solution brimonidine tartrate ALPHAGAN 0.2% Ophthalmic Solution brimonidine tartrate
Company Name ABBVIE CORPORATION ABBVIE CORPORATION
Ingredients BRIMONIDINE TARTRATE BRIMONIDINE TARTRATE
Strength(s) 0.2% 0.2%
Dosage form(s) LIQUID LIQUID
Route of administration OPHTHALMIC OPHTHALMIC OPHTHALMIC OPHTHALMIC
Packaging size 10mL 10mL
ATC code S01EA S01EA
ATC description ANTIGLAUCOMA PREPARATIONS AND MIOTICS ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2022-06-01 2022-06-01
Actual discontinuation date
Remaining supply date 2022-06-01 2022-06-01
Discontinuation status To be discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments 5mL package size available 5mL package size available
Health Canada comments